Revium Rx. Stock

Stocks

Market Closed - OTC Markets Other stock markets 09:30:09 2026-03-30 am EDT			5-day change	1st Jan Change
1.670 ^USD	+11.33%		-.--%	+221.15%

Jun. 22	Revium Rx. Announces Resignation of Inna Martin from Director, Chief Operating Officer and President, Effective June 16, 2026	CI
Jun. 01	Revium Rx. Announces CFO Changes, Effective May 27, 2026	CI

Jun. 22	Revium Rx. Announces Resignation of Inna Martin from Director, Chief Operating Officer and President, Effective June 16, 2026	CI
Jun. 01	Revium Rx. Announces CFO Changes, Effective May 27, 2026	CI
May. 14	Revium Rx. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
Apr. 20	Revium Rx. Appoints Amir Avraham as Permanent Chief Executive Officer, Effective as of February 1, 2026	CI
Apr. 20	Revium Rx. Appoints Shlomi Schwartzblat as Director and Chairman of the Board, Effective April 14, 2026	CI
Mar. 31	Revium Rx. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Mar. 30	Revium Rx. Auditor Raises 'Going Concern' Doubt	CI
Jan. 16	Revium Rx. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-10-21	Revium Recovery Inc. Advances Toward Phase 1 Clinical Development of Nano-Mupirocin to Combat Antibiotic-Resistant Infections	CI
25-10-03	Revium Rx. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-02-14	Revium Rx. has filed an IPO in the amount of $5 million.	CI
25-02-03	Revium Recovery Inc. completed the acquisition of LipoVac, Ltd.	CI
22-12-19	Revium Recovery Inc. entered into a letter of intent to acquire LipoVac, Ltd.	CI

25-10-21	Revium Rx Advances Toward Phase 1 Clinical Development of Nano-Mupirocin to Combat Antibiotic-Resistant Infections	GL
25-02-04	Revium Rx (RVRC) Completes Acquisition of LipoVation Ltd.	GL
22-12-21	Revium Recovery, Inc. Announces Letter of Intent to Acquire LipoVac Ltd	AQ
22-12-20	Revium Recovery, Inc. Announces Letter of Intent to Acquire LipoVac Ltd.	AQ
20-12-17	Correction: REVIUM RECOVERY ACQUIRES ANTI-ADDICTION REHABILITATION BUSINESS	GL

Manager	Title	Age	Since
Amir Avraham CEO	Chief Executive Officer	-	2025-05-21
Igor Bluvstein DFI	Director of Finance/CFO	46	2026-05-26
Inna Martin CEO	Chief Executive Officer	51	-

Director	Title	Age	Since
Inna Martin BRD	Director/Board Member	51	-
Matti Munk BRD	Director/Board Member	-	-
Yoram Druker BRD	Director/Board Member	-	-

Employees

Sector